# Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Study · id `cardio:ct-nct04462536` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04462536](<https://clinicaltrials.gov/study/NCT04462536>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04462536

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 850 participants.

## Technical summary

Registry record NCT04462536. Randomized; quadruple masking; primary purpose treatment. Start 2020-12-06 (actual); primary completion 2023-08-31 (actual). Results posted on 2025-06-22.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 850 participants (enrolled count; ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Started: 2020-12-06 (actual) (ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Primary completion: 2023-08-31 (actual) (ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Completion: 2023-08-31 (actual) (ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Results first posted: 2025-06-22 (ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Germany; Italy; Netherlands; Norway; Singapore; Switzerland (ClinicalTrials.gov record NCT04462536, source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04462536-2025-06-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
- Acronym: ESCAPE-NEXT
- Condition: Stroke, Acute
- Intervention (Drug): Placebo
- Intervention (Drug): Nerinetide
- Lead sponsor: NoNO Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: University of Calgary
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: NoNO Inc. (`cardio:org-nono-inc`)
- Registry lists this organization as a collaborator: University of Calgary (`cardio:org-university-of-calgary`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial (`cardio:pubmed-39955119`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d7d484057c23b4d33c1b12cbe0dc52b64f462fb78df632e2206a55e2dd3accde
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
